Download

    Confidence-Building Measure G

    Vaccine production facilities

    Janssen Vaccines, Branch of Cilag International GmbH

    01 - Disease targeted: COVID-19 -  Name of vaccine: Ad26.COV2.S - License: Emergency use US, BH

    02 - Disease targeted: Ebola virus disease -  Name of vaccine: Ad26.ZEBOV - License: EU

    03 - Disease targeted: Bacteremia; Urinary Tract Infections (extraenous pathogenic E.coli) -  Name of vaccine: ExPEC Multivalent - License: Phase 1/2a US, other countries

    EmergentBiosolutions Berna GmbH

    01 - Disease targeted: Typhoid fever -  Name of vaccine: Vivotif, Typhoral L - License: US, EU, CH, NO, UK, CA, AU, NZ, SG, MY, KR

    02 - Disease targeted: Cholera -  Name of vaccine: Vaxchora - License: US, EU

    02 - Disease targeted: Chikungunya fever -  Name of vaccine: no trade name yet - License: Phase 2 and 3 (US)

    Lonza AG

    01 - Disease targeted: COVID-19 -  Name of vaccine: mRNA-1273 (Moderna) - License: US, EU, CH, other countries

    Report Index